key features
Active Ingredient. Denosumab serves as the main component. It works as a human monoclonal antibody. This antibody helps by stopping bone resorption. It does that through targeting the RANK Ligand.
Administration. Doctors give it through a subcutaneous injection. Patients receive this once every six months. That means dosing happens just twice a year.
Indication. The drug treats osteoporosis in postmenopausal women. These are women who face a high risk of fractures. It also boosts bone mineral density. Plus, it lowers the overall risk of fractures.
Mechanism. It blocks the RANK Ligand first. That action prevents the activation of osteoclasts. As a result, bone breakdown decreases. In the end, bone mass goes up along with its strength.
Dosage Strength. Each prefilled syringe contains 60 mg of the drug. One such injection offers protection for a full six months.
Storage. Keep it refrigerated between 2 degrees Celsius and 8 degrees Celsius. Store it in the original carton. Avoid freezing it or shaking the syringe. It remains stable for up to 24 hours if left at room temperature.
Safety. Most people tolerate it quite well in general. You might notice common side effects like back pain. Extremity pain can occur too. Musculoskeletal pain shows up as another frequent issue.




















Reviews
There are no reviews yet.